Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-16-008903
Filing Date
2016-03-30
Accepted
2016-03-30 06:00:26
Documents
13
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 20-F f20f_032916.htm 20-F 1272957
2 EXHIBIT 8.1 exh_81.htm EX-8.1 2333
3 EXHIBIT 12.1 exh_121.htm EX-12.1 8523
4 EXHIBIT 12.2 exh_122.htm EX-12.2 8646
5 EXHIBIT 131.1 exh_131.htm EX-13.1 3714
6 EXHIBIT 13.2 exh_132.htm EX-13.2 3764
7 EXHIBIT 15.1 exh_151.htm EX-15.1 377299
8 GRAPHIC pipeline.jpg GRAPHIC 29596
9 GRAPHIC aptoeffect.jpg GRAPHIC 28971
10 GRAPHIC logo.jpg GRAPHIC 37966
11 GRAPHIC graph.jpg GRAPHIC 131948
12 GRAPHIC kpmg.jpg GRAPHIC 31015
13 GRAPHIC kpmg2.jpg GRAPHIC 29920
  Complete submission text file 0001171843-16-008903.txt   2077171
Mailing Address 5955 AIRPORT ROAD, SUITE 228 MISSISSAUGA A6 L4V 1R9
Business Address 5955 AIRPORT ROAD, SUITE 228 . MISSISSAUGA A6 L4V 1R9 647-479-9828
Aptose Biosciences Inc. (Filer) CIK: 0000882361 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-32001 | Film No.: 161536914
SIC: 2836 Biological Products, (No Diagnostic Substances)